OnKure Therapeutics, Inc. OKUR Conversion Of Convertible Note Payable
Conversion Of Convertible Note Payable at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept okur:ConversionOfConvertibleNotePayable.
The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s conversion of convertible note payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s conversion of convertible note payable?
- OnKure Therapeutics, Inc. (OKUR) reported conversion of convertible note payable of $1.53M in Q4 2024.
- What does conversion of convertible note payable mean?
- A non-cash financing activity where outstanding debt obligations are settled through the issuance of equity rather than cash. This conversion reduces future interest burdens and improves the company's balance sheet leverage profile.